Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Ophthalmology Groups Are Still Selling
Despite the effects of COVID-19 on physician groups, investors are still acquiring ophthalmology groups, especially in the third quarter, according to DSO. Just last week, EyeSouth Partners acquired Retina Associates of Middle Georgia (RAMG) for an undisclosed sum. Based in Macon, Georgia, RAMG provides treatment for the retina, macula, and vitreous diseases at two clinics in the middle Georgia area. The practice has three physicians. The affiliation represents EyeSouth’s eighth in the state of Georgia and eighteenth affiliation overall. EyeSouth is backed by Shore Capital Partners and is an eye care services organization in the southeast. Its affiliate network consists of 114... Read More »
Hospice M&A Activity Surges in 2020
Despite the volatile market conditions for healthcare M&A, hospice targets have remained a remarkably consistent draw for investors, according to data captured in DSO. In the second quarter of 2020, 70% of HH&H transactions were for hospice specific targets, or targets that provided only hospice services, instead of a mix of hospice and home health services. In Q1:20, only 22% of transactions focused on hospice targets, so it seems hospice demand is rising. So why are hospice targets continuing to attract investors, even as interest in home health targets slides? The appeal of the hospice market could be attributed to its stable reimbursement and payment rates compared with home... Read More »
Teladoc Health and Livongo Health Merge
The virtual care giant Teladoc Health, Inc. (NYSE: TDOC) is having a wild year. The company’s second-quarter earnings reports showed Teladoc’s year-over-year revenues surged by 85% to $241 million, and its total telehealth visits rose to 2.8 million, a year-over-year increase of 203%, all thanks to the effects of COVD-19. And now, Teladoc has announced a new merger with Livongo Health, Inc. (NASDAQ: LVGO) valued at $18.5 billion. Livongo is a leading Applied Health Signals company, using its AI+AI engine and a team of data scientists to aggregate and interpret substantial amounts of health data and information to create actionable, personalized health signals delivered to... Read More »
Health Care M&A Deals, August 7, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week was Teladoc Health, Inc.’s (NYSE: TDOC) acquisition of Livongo Health, Inc. (NASDAQ: LVGO) for $18.5 billion. The combination creates a global leader in consumer-centered virtual care. To subscribe to our Health Care M&A deals chart and more, visit our membership site. HealthCareMandA.com is devoted to healthcare merger and acquisition data for... Read More »
Varian and Siemens Healthineers Merge in Multi-Billion Dollar Deal
After a slow opening month for the third quarter, the merger between Varian Medical Systems (NYSE: VAR) and Siemens Healthineers AG (XETRA: SHL.DE) might bring some spark to the healthcare M&A market. Siemens Healthineers announced it was purchasing Varian for $16.4 billion, the largest deal of the year so far. Siemens Healthineers will acquire all shares of Varian for $177.50 per share in cash, a premium of approximately 24% to the closing price of Varian’s common stock on July 31, 2020. Varian generated trailing 12-month revenues of $3.2 billion and EBITDA of $536.3 million. For more than 70 years, Varian has developed, built, and delivered innovative cancer care technologies and... Read More »
SOC Telemed is Going Public in New Deal
One of the nations’ largest telemedicine providers is now going public. Specialists On Call, Inc. (d/b/a SOC Telemed) has been acquired by Healthcare Merger Corp. (NASDAQ: HCCO), a special purpose acquisition company, for $720 million from Warburg Pincus. Institutional Investors including BlackRock Inc., Baron Capital Group, and ClearBridge Investments, have committed to a private investment of $165 million in the combined company. SOC’s current management and equity holders, including Warburg Pincus, will roll a portion of their equity into the new SOC, and the proceeds generated by the transaction will be used to pay down existing debt. Once the merger is complete, the new company will... Read More »
WindRose Health Adds New Behavioral Health Platform
After a brief pause in the healthcare M&A market, WindRose Health Investors, LLC is back with a new investment. The private equity firm announced it acquired Caregiver Inc., a provider of behavioral services to adults with intellectual and developmental disabilities (IDD), for an undisclosed sum. It operates 800 properties in Texas, Tennessee, Indiana, and Ohio and employs 3,900 people. With WindRose’s investment, Caregiver will be able to expand into new markets across the United States and increase its market share within existing markets. WindRose purchased its stake from DW Healthcare Partners and Council Capital, who will both retain an ownership stake in the business going... Read More »
EyeCare Partners Had a Busy Second Quarter
It’s not surprising to find new deals weeks or months down the line, but EyeCare Partners announced a bunch of transactions from the second quarter — five to be exact — last week. EyeCare added Vitreous Retina Macula Specialists of New Jersey (Somerset, New Jersey), Foothills Eye Care (King, North Carolina ), 2020 Vision Care (St. Louis, Missouri), The Retina Clinic (Mine Hill, New Jersey), and Patel Retina Institute (Clarks Summit, Pennsylvania). EyeCare technically closed six deals in the second quarter, acquiring Phoenix-based Arizona Eye Institute & Cosmetic Laser Center, but that transaction was disclosed in late June, according to DSO. The six new acquisitions give... Read More »
Health Care M&A Deals, July 31, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is a global development and commercialization agreement for DS-1062 between AstraZeneca plc and Daiichi Sankyo Company valued at $1 billion. DS-1062 is Daiichi Sankyo’s proprietary trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC), and potential new medicine for the treatment of multiple tumor types. The companies will... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
